|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Product sales, net | |||||
| Operating Expenses: | |||||
| Cost of goods sold | |||||
| Gain on change in accounting estimates on contingent royalty liability (Note 7) | |||||
| Amortization of intangible asset | |||||
| Research and development | |||||
| Research and development, net | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Other expense, net | |||||
| Loss on issuance of financial instruments | |||||
| Gain on debt extinguishment, net | |||||
| Change in fair value of financial instruments | |||||
| Total other expense, net | |||||
| Income (loss) before income tax expense | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Deemed dividends | |||||
| Convertible preferred stock deemed dividends | |||||
| Net income (loss) attributable to common stockholders | |||||
| Net loss attributable to common stockholders | |||||
| Net income (loss) per share attributable to common stockholders: | |||||
| Basic (Note 2) | |||||
| Earnings Per Share, Diluted | |||||
| Weighted average number of shares outstanding basic | |||||
| Diluted | |||||
Loading...